To achieve this, we performed whole exome sequencing (WES) as well as targeted sequencing of the complementarity-determining region 3 of the BCR locus of malignant B cells isolated from leukemic Eμ-TCL1 mice and from animals after serial transplantation of leukemia cells in syngeneic wild-type (WT) mice. This evidence concerns the gene BCR and leukemia.